{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T12:07:49Z","timestamp":1790078869091,"version":"4.0.1"},"reference-count":54,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan, R.O.C.","doi-asserted-by":"crossref","award":["MOST 101-2320-B-039-038"],"award-info":[{"award-number":["MOST 101-2320-B-039-038"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan, R.O.C.","doi-asserted-by":"crossref","award":["MOST 102-2320-B-039-043-MY3"],"award-info":[{"award-number":["MOST 102-2320-B-039-043-MY3"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004391","name":"China Medical University Hospital, Taichung, Taiwan","doi-asserted-by":"crossref","award":["DMR-105-087"],"award-info":[{"award-number":["DMR-105-087"]}],"id":[{"id":"10.13039\/501100004391","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004391","name":"China Medical University Hospital, Taichung, Taiwan","doi-asserted-by":"crossref","award":["DMR-105-066"],"award-info":[{"award-number":["DMR-105-066"]}],"id":[{"id":"10.13039\/501100004391","id-type":"DOI","asserted-by":"crossref"}]},{"name":"China Medical University, Taichung, Taiwan","award":["CMU102-ASIA-09"],"award-info":[{"award-number":["CMU102-ASIA-09"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","cancerletters.info","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.canlet.2016.02.047","type":"journal-article","created":{"date-parts":[[2016,3,2]],"date-time":"2016-03-02T17:20:53Z","timestamp":1456939253000},"page":"303-312","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["The anti-proliferative effects of type I IFN involve STAT6-mediated regulation of SP1 and BCL6"],"prefix":"10.1016","volume":"375","author":[{"given":"Yu-An","family":"Hsu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Chun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yung-Jen","family":"Kung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Ju","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ching-Yao","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuan-Rong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2016.02.047_bib0010","first-page":"2489","article-title":"Biological properties of recombinant alpha-interferons: 40th anniversary of the discovery of interferons","volume":"58","author":"Pfeffer","year":"1998","journal-title":"Cancer Res"},{"key":"10.1016\/j.canlet.2016.02.047_bib0015","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/jcp.20137","article-title":"Alpha-interferon and its effects on signal transduction pathways","volume":"202","author":"Caraglia","year":"2005","journal-title":"J. Cell. Physiol"},{"key":"10.1016\/j.canlet.2016.02.047_bib0020","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1038\/sj.onc.1203524","article-title":"Jak-Stat signal transduction pathway through the eyes of cytokine class II receptor complexes","volume":"19","author":"Kotenko","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2016.02.047_bib0025","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/BF02981951","article-title":"Role of Jak kinases and STATs in cytokine signal transduction","volume":"73","author":"Leonard","year":"2001","journal-title":"Int. J. Hematol"},{"key":"10.1016\/j.canlet.2016.02.047_bib0030","doi-asserted-by":"crossref","first-page":"3249","DOI":"10.1073\/pnas.84.10.3249","article-title":"Cytoskeletal association of human alpha-interferon-receptor complexes in interferon-sensitive and -resistant lymphoblastoid cells","volume":"84","author":"Pfeffer","year":"1987","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.canlet.2016.02.047_bib0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1074-7613(00)80505-1","article-title":"Jaks, STATs, cytokine signal transduction, and immunoregulation: are we there yet?","volume":"7","author":"O'Shea","year":"1997","journal-title":"Immunity"},{"key":"10.1016\/j.canlet.2016.02.047_bib0040","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1126\/science.1496401","article-title":"Interferon-dependent tyrosine phosphorylation of a latent cytoplasmic transcription factor","volume":"257","author":"Schindler","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.canlet.2016.02.047_bib0045","doi-asserted-by":"crossref","first-page":"7836","DOI":"10.1073\/pnas.89.16.7836","article-title":"Proteins of transcription factor ISGF-3: one gene encodes the 91- and 84-kDa ISGF-3 proteins that are activated by interferon a.","volume":"89","author":"Schindler","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.canlet.2016.02.047_bib0050","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1038\/sj.onc.1203485","article-title":"The biology of Stat4 and Stat6","volume":"19","author":"Wurster","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2016.02.047_bib0055","doi-asserted-by":"crossref","first-page":"8057","DOI":"10.1074\/jbc.271.14.8057","article-title":"Direct association of STAT3 with the IFNAR-1 chain of the human type I interferon receptor","volume":"271","author":"Yang","year":"1996","journal-title":"J. Biol. Chem"},{"key":"10.1016\/j.canlet.2016.02.047_bib0060","doi-asserted-by":"crossref","first-page":"6937","DOI":"10.1128\/MCB.16.12.6937","article-title":"Activation of different Stat5 isoforms contributes to cell-type-restricted signaling in response to interferons","volume":"16","author":"Meinke","year":"1996","journal-title":"Mol. Cell. Biol"},{"key":"10.1016\/j.canlet.2016.02.047_bib0065","doi-asserted-by":"crossref","first-page":"4781","DOI":"10.4049\/jimmunol.157.11.4781","article-title":"Activation of STAT4 by IL-12 and IFN-alpha: evidence for the involvement of ligand-induced tyrosine and serine phosphorylation","volume":"157","author":"Cho","year":"1996","journal-title":"J. Immunol"},{"key":"10.1016\/j.canlet.2016.02.047_bib0070","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.critrevonc.2005.08.005","article-title":"The role of constitutively active Stat6 in leukemia and lymphoma","volume":"57","author":"Bruns","year":"2006","journal-title":"Crit. Rev. Oncol. Hematol"},{"key":"10.1016\/j.canlet.2016.02.047_bib0075","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1146\/annurev.immunol.23.021704.115821","article-title":"Regulation of Th2 differentiation and Il4 locus accessibility","volume":"24","author":"Ansel","year":"2006","journal-title":"Annu. Rev. Immunol"},{"key":"10.1016\/j.canlet.2016.02.047_bib0080","doi-asserted-by":"crossref","first-page":"6015","DOI":"10.4049\/jimmunol.165.11.6015","article-title":"Cutting edge: STAT6-deficient mice have enhanced tumor immunity to primary and metastatic mammary carcinoma","volume":"165","author":"Ostrand-Rosenberg","year":"2000","journal-title":"J. Immunol"},{"key":"10.1016\/j.canlet.2016.02.047_bib0085","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/s00262-003-0446-z","article-title":"Signal transducer and activator of transcription 6 (Stat6) and CD1: inhibitors of immunosurveillance against primary tumors and metastatic disease","volume":"53","author":"Ostrand-Rosenberg","year":"2004","journal-title":"Cancer Immunol. Immunother"},{"key":"10.1016\/j.canlet.2016.02.047_bib0090","doi-asserted-by":"crossref","first-page":"6024","DOI":"10.4049\/jimmunol.165.11.6024","article-title":"Spontaneous rejection of poorly immunogenic P1.HTR tumors by stat6-deficient mice","volume":"165","author":"Kacha","year":"2000","journal-title":"J. Immunol"},{"key":"10.1016\/j.canlet.2016.02.047_bib0095","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0378-1119(99)00357-1","article-title":"The Sp-family of transcription factors","volume":"238","author":"Suske","year":"1999","journal-title":"Gene"},{"key":"10.1016\/j.canlet.2016.02.047_bib0100","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1002\/j.1460-2075.1992.tb05235.x","article-title":"The same dorsal binding site mediates both activation and repression in a context-dependent manner","volume":"11","author":"Pan","year":"1992","journal-title":"EMBO J."},{"key":"10.1016\/j.canlet.2016.02.047_bib0105","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.jaci.2010.11.013","article-title":"Specificity protein 1 is pivotal in the skin's antiviral response","volume":"127","author":"Bin","year":"2011","journal-title":"J. Allergy Clin. Immunol"},{"key":"10.1016\/j.canlet.2016.02.047_bib0110","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/sj.onc.1206152","article-title":"Ambivalent role of BCL6 in cell survival and transformation","volume":"22","author":"Albagli-Curiel","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2016.02.047_bib0115","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/S0002-9440(10)62564-3","article-title":"A short mutational hot spot in the first intron of BCL-6 is associated with increased BCL-6 expression and with longer overall survival in large B-cell lymphomas","volume":"160","author":"Artiga","year":"2002","journal-title":"Am. J. Pathol"},{"key":"10.1016\/j.canlet.2016.02.047_bib0120","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1084\/jem.20110304","article-title":"BCL6-mediated repression of p53 is critical for leukemia stem cell survival in chronic myeloid leukemia","volume":"208","author":"Hurtz","year":"2011","journal-title":"J. Exp. Med"},{"key":"10.1016\/j.canlet.2016.02.047_bib0125","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/nature03148","article-title":"The BCL6 proto-oncogene suppresses p53 expression in germinal-centre B cells","volume":"432","author":"Gallavotti","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2016.02.047_bib0130","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1182\/blood-2014-06-582650","article-title":"Activating STAT6 mutations in follicular lymphoma","volume":"125","author":"Yildiz","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2016.02.047_bib0135","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1182\/blood-2009-03-209759","article-title":"Recurrent mutations of the STAT6 DNA binding domain in primary mediastinal B-cell lymphoma","volume":"114","author":"Ritz","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2016.02.047_bib0140","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.cytogfr.2006.01.004","article-title":"Signaling mechanisms, interaction partners, and target genes of STAT6","volume":"17","author":"Hebenstreit","year":"2006","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.canlet.2016.02.047_bib0145","doi-asserted-by":"crossref","first-page":"4529","DOI":"10.1182\/blood.V92.12.4529","article-title":"Stat6 inhibits human interleukin-4 promoter activity in T cells","volume":"92","author":"Georas","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2016.02.047_bib0150","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1002\/j.1460-2075.1994.tb06388.x","article-title":"STF-IL-4: a novel IL-4-induced signal transducing factor","volume":"13","author":"Schindler","year":"1994","journal-title":"EMBO J."},{"key":"10.1016\/j.canlet.2016.02.047_bib0155","doi-asserted-by":"crossref","first-page":"3066","DOI":"10.1002\/eji.1830231204","article-title":"Allergy-associated I epsilon and Ec epsilon receptor II (CD23b) genes activated via binding of an interleukin-4-induced transcription factor to a novel responsive element","volume":"23","author":"Kohler","year":"1993","journal-title":"Eur. J. Immunol"},{"key":"10.1016\/j.canlet.2016.02.047_bib0160","doi-asserted-by":"crossref","first-page":"27808","DOI":"10.1074\/jbc.M109.028324","article-title":"Interferon-resistant Daudi cell line with a Stat2 defect is resistant to apoptosis induced by chemotherapeutic agents","volume":"284","author":"Du","year":"2009","journal-title":"J. Biol. Chem"},{"key":"10.1016\/j.canlet.2016.02.047_bib0165","first-page":"S9-99","article-title":"Increasing effectiveness of interferon-alpha for malignancies","volume":"24","author":"Lindner","year":"1997","journal-title":"Semin. Oncol"},{"key":"10.1016\/j.canlet.2016.02.047_bib0170","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/0753-3322(96)85288-7","article-title":"The role of interferon in the therapy of malignant lymphoma","volume":"50","author":"McLaughlin","year":"1996","journal-title":"Biomed. Pharmacother"},{"key":"10.1016\/j.canlet.2016.02.047_bib0175","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1158\/0008-5472.CAN-11-2651","article-title":"Type I and II IFNs inhibit Merkel cell carcinoma via modulation of the Merkel cell polyomavirus T antigens","volume":"72","author":"Willmes","year":"2012","journal-title":"Cancer Res"},{"key":"10.1016\/j.canlet.2016.02.047_bib0180","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1126\/science.8197455","article-title":"Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins","volume":"264","author":"Darnell","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.canlet.2016.02.047_bib0185","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1006\/geno.1995.1235","article-title":"Distribution of the mammalian Stat gene family in mouse chromosomes","volume":"29","author":"Copeland","year":"1995","journal-title":"Genomics"},{"key":"10.1016\/j.canlet.2016.02.047_bib0190","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1126\/science.277.5332.1630","article-title":"STATs and gene regulation","volume":"277","author":"Darnell","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.canlet.2016.02.047_bib0195","doi-asserted-by":"crossref","first-page":"3834","DOI":"10.4049\/jimmunol.163.7.3834","article-title":"IFN-alpha activates Stat6 and leads to the formation of Stat2:Stat6 complexes in B cells","volume":"163","author":"Gupta","year":"1999","journal-title":"J. Immunol"},{"key":"10.1016\/j.canlet.2016.02.047_bib0200","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1046\/j.1432-1327.1998.2540514.x","article-title":"Interferon-alpha activates signal transducers and activators of transcription 5 and 6 in Daudi cells","volume":"254","author":"Fasler-Kan","year":"1998","journal-title":"Eur. J. Biochem"},{"key":"10.1016\/j.canlet.2016.02.047_bib0205","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1111\/j.1582-4934.2008.00143.x","article-title":"Type I IFN induced IL1-Ra expression in hepatocytes is mediated by activating STAT6 through the formation of STAT2: STAT6 heterodimer","volume":"12","author":"Wan","year":"2008","journal-title":"J. Cell. Mol. Med"},{"key":"10.1016\/j.canlet.2016.02.047_bib0210","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.immuni.2010.06.011","article-title":"Genome-wide profiling of interleukin-4 and STAT6 transcription factor regulation of human Th2 cell programming","volume":"32","author":"Elo","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.canlet.2016.02.047_bib0215","doi-asserted-by":"crossref","first-page":"22617","DOI":"10.1073\/pnas.1009152108","article-title":"IL-4\/STAT6 immune axis regulates peripheral nutrient metabolism and insulin sensitivity","volume":"107","author":"Ricardo-Gonzalez","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.canlet.2016.02.047_bib0220","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s13402-012-0115-3","article-title":"Stat6 cooperates with Sp1 in controlling breast cancer cell proliferation by modulating the expression of p21(Cip1\/WAF1) and p27 (Kip1)","volume":"36","author":"Wei","year":"2013","journal-title":"Cell. Oncol. (Dordr.)"},{"key":"10.1016\/j.canlet.2016.02.047_bib0225","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/jcp.1111","article-title":"Sp1 and kruppel-like factor family of transcription factors in cell growth regulation and cancer","volume":"188","author":"Black","year":"2001","journal-title":"J. Cell. Physiol"},{"key":"10.1016\/j.canlet.2016.02.047_bib0230","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S0092-8674(00)80243-3","article-title":"Transcription factor Sp1 is essential for early embryonic development but dispensable for cell growth and differentiation","volume":"89","author":"Marin","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2016.02.047_bib0235","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1158\/0008-5472.1007.65.3","article-title":"Down-regulation of overexpressed sp1 protein in human fibrosarcoma cell lines inhibits tumor formation","volume":"65","author":"Lou","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.canlet.2016.02.047_bib0240","doi-asserted-by":"crossref","first-page":"7096","DOI":"10.1038\/sj.onc.1209696","article-title":"Overexpression of Sp1 transcription factor induces apoptosis","volume":"25","author":"Deniaud","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2016.02.047_bib0245","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1002\/ijc.24563","article-title":"Overexpression of Sp1 leads to p53-dependent apoptosis in cancer cells","volume":"125","author":"Chuang","year":"2009","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.canlet.2016.02.047_bib0250","doi-asserted-by":"crossref","first-page":"5063","DOI":"10.1038\/sj.onc.1202892","article-title":"Overexpressed BCL6 (LAZ3) oncoprotein triggers apoptosis, delays S phase progression and associates with replication foci","volume":"18","author":"Albagli","year":"1999","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2016.02.047_bib0255","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/sj.onc.1202334","article-title":"Adenovirus-mediated high expression of BCL-6 in CV-1 cells induces apoptotic cell death accompanied by down-regulation of BCL-2 and BCL-X(L)","volume":"18","author":"Yamochi","year":"1999","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2016.02.047_bib0260","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S1074-7613(00)00020-0","article-title":"BCL-6 represses genes that function in lymphocyte differentiation, inflammation, and cell cycle control","volume":"13","author":"Shaffer","year":"2000","journal-title":"Immunity"},{"key":"10.1016\/j.canlet.2016.02.047_bib0265","doi-asserted-by":"crossref","first-page":"17634","DOI":"10.1074\/jbc.273.28.17634","article-title":"Mutational analysis of the STAT6 SH2 domain","volume":"273","author":"Mikita","year":"1998","journal-title":"J. Biol. Chem"},{"key":"10.1016\/j.canlet.2016.02.047_bib0270","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/1074-7613(95)90013-6","article-title":"Components of a Stat recognition code: evidence for two layers of molecular selectivity","volume":"2","author":"Schindler","year":"1995","journal-title":"Immunity"},{"key":"10.1016\/j.canlet.2016.02.047_bib0275","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1128\/MCB.15.3.1312","article-title":"Role of STAT2 in the alpha interferon signaling pathway","volume":"15","author":"Leung","year":"1995","journal-title":"Mol. Cell. Biol"}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383516301252?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383516301252?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T03:05:08Z","timestamp":1692241508000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383516301252"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":54,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["S0304383516301252"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2016.02.047","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The anti-proliferative effects of type I IFN involve STAT6-mediated regulation of SP1 and BCL6","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2016.02.047","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}